Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy

This study provides Class IV evidence that anti-NF155 antibodies associate with a specific phenotype and response to rituximab.

Source: Neurology Neuroimmunology and Neuroinflammation - November 2, 2021 Category: Neurology Authors: Martin-Aguilar, L., Lleixa, C., Pascual-Goni, E., Caballero-Avila, M., Martinez-Martinez, L., Diaz-Manera, J., Rojas-Garcia, R., Cortes-Vicente, E., Turon-Sans, J., de Luna, N., Suarez-Calvet, X., Gallardo, E., Rajabally, Y., Scotton, S., Jacobs, B. C., B Tags: Chronic inflammatory demyelinating polyneuropathy, Class IV Article Source Type: research